Carcinostatic activity of a thiazolidinonylidene-hydrazonothiazolidinone derivative against DMBA-induced mammary carcinomata in female Sprague-Dawley rats.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001551:Benz(a)Anthracenes; D001943:Breast Neoplasms / Q000139:chemically induced / Q000188:drug therapy*; D002277:Carcinoma / Q000139:chemically induced / Q000188:drug therapy*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005260:Female; D006835:Hydrazones / Q000627:therapeutic use; D009374:Neoplasms, Experimental; D051381:Rats; D013844:Thiazoles / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001551:Benz(a)Anthracenes; D006835:Hydrazones; D013844:Thiazoles